| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8458749 | Radiotherapy and Oncology | 2018 | 6 Pages |
Abstract
OS after SRT was comparable to SM and longer than expected considering patients with adverse risk profiles were common. Fit patients with non-brain metastases treated after an initial period of watchful waiting had the best prognosis.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
M. Stenman, G. Sinclair, P. Paavola, P. Wersäll, U. Harmenberg, M. Lindskog,